Latest News

August 22, 2011
Children with severe asthma are 3.6 times more likely to have been exposed to tobacco smoking before birth – even without later exposure – than children with a mild form of the disease, according to a multicenter study led by researchers at University of California, San Francisco (UCSF).
May 05, 2011
UCSF's basic research over nearly two decades has led to the first novel antitoxin to treat botulism in nearly a century – becoming the first recombinant human therapy to target one of the most dangerous substances known to man and offering a new defense against bioterrorism.
February 28, 2011
UCSF and Zcube have entered into a new agreement to license UCSF-developed microtechnology and support early research into new ways to deliver oral medications directly to a targeted site in the body.
February 03, 2011
UCSF neurosurgeons and an MRI physicist have pioneered a faster, more accurate and less invasive surgical technique for treating patients with movement disorders, potentially changing the future of neurosurgery.
December 15, 2010
Weight gain and environmental pollutants might be linked, an award-winning worm researcher suggests.
December 13, 2010
UCSF researchers have identified an existing medication that restores key elements of the immune system that, when out of balance, lead to a steady decline in immunity and health as people age.
November 01, 2010
Anti-inflammatory drugs currently used to treat diseases such as rheumatoid arthritis may also help prevent cognitive decline after surgery, according to a new study led by researchers at UCSF and colleagues at Imperial College London.
November 01, 2010
Rapamycin, an FDA-approved drug prescribed to prevent the rejection of transplanted organs, has been shown for the first time to decrease excessive alcohol consumption, binge drinking, and alcohol-seeking behavior in rodents.
October 22, 2010
UCSF scientists have received two grants from the California Institute for Regenerative Medicine to refine their human embryonic stem cell-based strategies for treating neurological diseases and liver failure.
September 21, 2010
An inexpensive, hundred-year-old therapy for pain – aspirin – is effective in high doses for the treatment of severe headache and migraine caused by drug withdrawal, according to a new study by researchers with the UCSF Headache Center.

Pages